Renal Pharmacotherapy: Dosage Adjustment of Medications Eliminated by the Kidneys

As the population of patients with acute or chronic kidney disease grows, healthcare professionals need a resource that optimizes drug effectiveness while minimizing potential toxicity.  Renal Pharmacotherapy is a comprehensive listing of dosage recommendations for patients with compromised renal function.  This up-to-date and evidence-based reference closes several identified knowledge gaps concerning medications eliminated by the kidneys.

 

Conveniently listed alphabetically by generic drug name, each drug has its own face page featuring typical dosing ranges, alternative dosing adjustments by strata of renal function, specific dosing for dialysis and other dosing schemes.

 

This work will satisfy the dosing information needs of busy physicians involved in pharmacotherapy for patients with kidney disease, as well as pharmacists, nurses and students.

 

Larry Golightly is the lead author of this book and currently the Clinical Assnt Professor at the University of Colorado Skaggs Schook of Pharmacy and Pharmaceutical Sciences. Dr. Golightly is a thought leader in pharmacy science and has been an invited presentor to domestic and international conferences and committees. The following assisted Dr. Golightly in preparing this book: Isaac Teitelbaum, MD, FACP Tyree H. Kiser, PharmD, BCPS Dimitriy R. Levin, MD Gerard R. Barber, RPh, MPH, FASHP Michael A. Jones, PharmD Nancy M. Stolpman, PharmD, PhD Katherine S. Lundin, PharmD Every author is at the University of Colorado Hospital in Aurora, CO.

Table Of Contents

About Larry K Golightly